Search Results 741-750 of 1859 for ai润色文章网站,网上的ai聊天,ai绘画壁纸网站,ai平面设计网址,ai填色网站,等欢迎访问豌豆Ai站群搜索引擎系统官方网站:www.wd.chat

1. Evaluate the Effect of ALLN-177 in Reducing Urinary Oxalate in Patients With Secondary Hyperoxaluria and Kidney Stones Over 28 Days - Mayo Clinic

   About this study. Evaluate the safety, tolerability, and efficacy of 28 days of treatment with ALLN-177 for reducing urinary oxalate excretion in patients ...

2. First In Human Study Of TUB-030 In Patients With Advanced Solid Tumors - Mayo Clinic

   About this study. The goal of this clinical trial is to learn if the drug TUB-030 works to treat solid cancer in adults. The study will also explore the ...

3. A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 - Mayo Clinic

   About this study. The purpose of this study is to evaluate the effectiveness, safety, pharmacokinetics (PK), and pharmacodynamics (PD) of lumasiran in ...

4. Integration of Fluid Integration of Fluid and Imaging-Based Markers for Prostate Cancer - Mayo Clinic

   About this study. The purpose of this study is to refine the current diagnostic algorithm and improve the pre-biopsy detection of high-grade prostate cancer ...

5. Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) - Mayo Clinic

   Efficacy, Safety, and Tolerability of Oral Full-Spectrum Microbiota® (CP101) in Subjects with Recurrence of Clostridium difficile Infection (PRISM3) · Overview.

6. Characterization of Biliary Cell-derived Organoids from Bile of PSC and Non-PSC Patients - Mayo Clinic

   About this study. The objectives of this study are to establish and perpetuate human biliary cell-derived organoids, to assess genetic and signaling pathway ...

7. Funding - Research

   View funding sources for the Epigenetic Etiology of Human Disease Lab led by Keith Robertson, Ph.D., at Mayo Clinic's campus in Minnesota.

8. A Study to Evaluate Patiromer for the Management of Hyperkalemia in Subjects Receiving Renin-Angiotensin Aldosterone System Inhibitor (RAASi) Medications for the Treatment of Heart Failure (DIAMOND) - Mayo Clinic

   About this study. The purpose of this study is to determine if patiromer treatment of subjects who developed hyperkalemia while receiving RAASi medications ...

9. AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis - Mayo Clinic

   This study is a placebo-controlled Phase I study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of the antisense oligonucleotide ( ...

10. A Study of Napabucasin Plus Nab-Paclitaxel With Gemcitabine in Adult Patients With Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...